日本語 >>
TOP page
Current specialization
Journal Articles
Presentations
Professional Organizations
（Last updated : 2026-04-28 14:41:55）
Sumie Asano
Department
Kawasaki Medical School Kawasaki Medical School, Department of Rheumatology,
Position
Assistant Professor
■
Current specialization
Connective tissue disease and allergy
■
Journal Articles
1.
2020/06
Risk Factors for Chronic Damage Accumulation Across Different Onset Eras in Systemic Lupus Erythematosus: A Cross-sectional Analysis of a Lupus Registry of Nationwide Institutions (LUNA).
2.
2026/01/21
A case of concurrent cold agglutinin disease and C3 glomerulonephritis requiring differentiation from other iatrogenic immunodeficiency-associated lymphoproliferative disorder in a patient with rheumatoid arthritis and Sjögren's disease
3.
2025/05/22
Coexistence of IgG4-Related Disease and Renal Anastomosing Hemangioma: A Rare Diagnostic Challenge
4.
2025/02/26
Clinical Significance of Antinuclear Antibodies in Patients with Rheumatoid Arthritis: From SETOUCHI-RA Registry
5.
2024/03/21
Prognosis and prognostic factors of lung cancer complications in patients with rheumatoid arthritis
6.
2023/06/07
ANCA-associated vasculitis with scleritis, corneal melt, and perforation rescued by rituximab: Case report and literature
7.
2022/07/22
TRAPS mutations in
Tnfrsf1a
decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1
8.
2022/05/14
IL-17A promotes vascular calcification in an ex vivo murine aorta culture
9.
2022/04/13
Obesity and Dyslipidemia Synergistically Exacerbate Psoriatic Skin Inflammation
10.
2022/03/10
IL-17A promotes vascular calcification in an ex vivo murine aorta culture
11.
2022
Therapeutic Approaches Targeting miRNA in Systemic Lupus Erythematosus
12.
2021/11/07
Imatinib has minimal effects on inflammatory and osteopenic phenotypes in a murine cherubism model
13.
2021/04/17
SH3BP2 Deficiency Ameliorates Murine Systemic Lupus Erythematosus.
14.
2021/03/10
Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study
15.
2021/01/26
Deletion of Mir223 exacerbates lupus nephritis by targeting S1pr1 in Faslpr/lpr mice
16.
2021/01/22
Granulomatosis with polyangiitis with obstructive pneumonia progressing to hypertrophic pachymeningitis: A case report
17.
2020/10/30
Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis
18.
2020/06
Association of Explanatory Histological Findings and Urinary Protein and Serum Creatinine Levels at Renal Biopsy in Lupus Nephritis: A Cross-Sectional Study
19.
2020/02/29
Damage accrual related to pregnancies before and after diagnosis of systemic lupus erythematosus: a cross-sectional and nested case-control analysis from a lupus registry.
20.
2019/09
Cluster Analysis Using Anti-Aminoacyl-tRNA Synthetases and SS-A/Ro52 antibodies in Patients With Polymyositis/Dermatomyositis.
21.
2019/07/18
Thrombocytosis as a prognostic factor in polymyalgia rheumatica: characteristics determined from cluster analysis.
22.
2019/07/10
Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
23.
2019/06/14
Capnocytophaga canimorsus peritonitis diagnosed by mass spectrometry in a diabetic patient undergoing peritoneal dialysis: a case report.
24.
2019/06
Inflammatory myopathy associated with PD-1 inhibitors.
25.
2019/02/28
Regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice derived CD4+ T cells.
26.
2018/11
Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
27.
2018/10/04
An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin.
28.
2018/07
Refractory neuromyelitis optica spectrum disorder in systemic lupus erythematosus successfully treated with rituximab.
29.
2018/07
Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
30.
2018/01
Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositis.
31.
2017/09
Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF Therapy.
32.
2017/09
Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
33.
2017/07
Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
34.
2017/06/01
Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells.
35.
2017/05
A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy.
36.
2017/05
Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice.
37.
2017/05
LXR, PPARγ, and PPARδ agonists are not sufficient to demonstrate therapeutic potential against mouse model of systemic lupus erythematosus.
38.
2016
Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.
39.
2012/09
Fatty acid-binding protein 4 (FABP4) and FABP5 modulate cytokine production in the mouse thymic epithelial cells.
Display 5 items
Display all(39)
■
Presentations
1.
2026/04/23
Baseline IgM/IgG Ratio as a Biomarker for Effectiveness of Rituximab in Systemic Sclerosis-Related Interstitial Lung Disease （Speech，General）
2.
2026/04/23
Clinical Characteristics and Risk Factors for Persistent D2TRA～Findings from the SETOUCHI-RA Registry～ （Speech，General）
3.
2026/04/23
Risk Factors for Early Discontinuation of Avacopan in Patients with ANCA-Associated Vasculitis （Speech，General）
4.
2025/04/25
Clinical Relevance of Radial and Ulnar Artery Diameter Measurement Using Vascular Ultrasonography in Patients with Systemic Sclerosis （Speech，General）
5.
2022/04/27
Obesity and hyperlipidemia synergistically exacerbate psoriatic skin inflammation （General）
6.
2022/04/25
Deletion of Mir223 exacerbates lupus nephritis by targeting S1pr1 in Faslpr/lpr mice （Speech，General）
7.
2021/12/08
The investigation of the pathogenesis of TNF Receptor-Associated Periodic Syndrome (TRAPS) using murine TRAPS models （Poster notice，General）
8.
2021/11/12
Deletion of Mir223 exacerbates lupus nephritis by targeting S1pr1 in Faslpr/lpr mice （Poster notice，General）
9.
2021/08/28
The study of the pathogenesis of TNF Receptor-Associated Periodic Syndrome (TRAPS) using murine TRAPS models （Speech，General）
10.
2020/12/04
The role of an adaptor protein SH3BP2 in the pathogenesis of systemic lupus erythematosus （Poster notice，General）
11.
2020/12/02
Deletion of Mir223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Fas lpr/lpr Mice （Poster notice，General）
12.
2020/11/05
Deletion of miR-223 exacerbates lupus nephritis by targeting S1pr1 in Faslpr/lpr mice （Poster notice，General）
13.
2020/10/24
Deletion of miR-223 exacerbates lupus nephritis by targeting S1pr1 in Faslpr/lpr mice （Poster notice，General）
14.
2020/08/17
The reduction of S1pr1 by miR223-3p and their roles in the pathogenesis of SLE （Poster notice，General）
15.
2018/04/27
DNA Methylation-dependent regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice. （Speech，General）
16.
2017/12/13
DNA Methylation-dependent regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice. （Speech，General）
17.
2017/09/18
DNA Methylation-dependent regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice. （Speech，General）
18.
2017/04/21
DNA Methylation-dependent regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice. （Speech，General）
19.
2016/12/07
DNA Methylation-dependent regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice. （Speech，General）
20.
2016/04/21
Clinical course and treatment of two refractory cases of antiHMGCR antibody-associated necrotizing autoimmune myopathy （Speech，General）
Display 5 items
Display all(20)
■
Professional Organizations
1.
2013/03～
The Japanese Society of Internal Medicine
2.
2013/09～
Japan College of Rheumatology
3.
2015/06～
The Japanese Society of Clinical Immunology
4.
2016/02～
Japanese Society for Immunology
5.
2020/08～
The Molecular Biology Society of Japan
